A. Nageswaran et al., HOSPITAL-SERVICE UTILIZATION BY HIV AIDS PATIENTS AND THEIR MANAGEMENT COST IN A PROVINCIAL GENITOURINARY MEDICINE DEPARTMENT, International journal of STD & AIDS, 6(5), 1995, pp. 336-344
The hospital management of 108 HIV/AIDS patients cared for by the geni
tourinary medicine department, Sheffield, UK between 1984-93 was retro
spectively studied to quantify the services utilized by these patients
and to detail the management costs (1993 price) of outpatient (OF) se
rvices, inpatient (IP) care, investigational services and therapeutic
provisions. The services utilized and cost are presented separately fo
r the different clinical stages of the infection and as per patient ye
ar. Of the 108 patients, 95 (88%) were males and 13 (12%) females; mos
t males (76.8%) acquired the infection through homosexual exposure, wh
ile 46% of females acquired it heterosexually. The mean number of OP c
onsultation per asymptomatic, symptomatic non-AIDS and AIDS patient ye
ars were 11.6, 16.4 and 32.8 respectively; the mean number of IP episo
des for each of these clinical groups were 0.15, 0.83 and 3.88 with IP
stays 0.7, 3.5 and 40.6 days per patient year respectively. The annua
l costs of OP care ($45.26 per consultation), drugs and investigations
were, respectively $525, $213 and $153 per asymptomatic patient year,
$742, $2097 and $224 per symptomatic non AIDS patient year and $1485,
$2928 and $382 per AIDS patient year. The average annual OP drug cost
per patient year showed little change since 1988. However, in the AID
S group, contributions from differing drug classes showed significant
changes; while the contribution of antiretroviral drugs fell from 80.2
% of the drug cost per AIDS patient year in 1990 to 31.3% in 1993, tha
t from antibiotics rose from 0.3% in 1990 to 26.4% in 1993 and other a
ntivirals from 9.4% in 1988 to 22.6% in 1993. These changes were relat
ed to lower recommended daily dosage of zidovudine and to wider prescr
iption of antibiotics for atypical mycobacterial infections and domici
liary gancyclovir for CMV infection. The costs of annual mean IP care,
IP drugs, IP investigations and IP procedures per AIDS patient year w
ere $5926 ($146 per IP stay), $2983, $282 and $145 respectively. The o
verall management cost of one AIDS patient year was $14 131 and lifeti
me AIDS management cost, based on a mean survival of 17 months, a Litt
le more than $20 000. The annual management cost of an asymptomatic an
d symptomatic non-AIDS patient year is approximately 1/14th and 1/4th
of the cost of an AIDS patient year.